Tech Company Financing Transactions

SynGen Funding Round

SynGen closed a $500 thousand financing round on 2/28/2017. Backers included private investors.

Transaction Overview

Company Name
Announced On
2/28/2017
Transaction Type
Debt
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2711 Citrus Rd.
Rancho Cordova, CA 95742
USA
Email Address
Overview
At SynGen Inc. we develop advanced cell separation tools and accessories, applying innovative design to aid regenerative medicine workflows.
Profile
SynGen LinkedIn Company Profile
Social Media
SynGen Company Twitter Account
Company News
SynGen News
Facebook
SynGen on Facebook
YouTube
SynGen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Xu
  Chris Xu LinkedIn Profile  Chris Xu Twitter Account  Chris Xu News  Chris Xu on Facebook
Chief Technical Officer
Philip Coelho
  Philip Coelho LinkedIn Profile  Philip Coelho Twitter Account  Philip Coelho News  Philip Coelho on Facebook
VP - General Counsel
James Xu
  James Xu LinkedIn Profile  James Xu Twitter Account  James Xu News  James Xu on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/28/2017: PartySlate venture capital transaction
Next: 2/28/2017: Voicera venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary